1 / 6

Global Autoinjector Market to Witness 16.9% CAGR During 2018 – 2024, Attaining the Market Size of USD 4.5 Billion by 202

The global autoinjector market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The market is driven by the factorssuch as high prevalence of chronic and lifestyle associated diseases, increasing number of regulatory approvals, technology anddesign improvement, escalating patient attentiveness and inclination of patients regarding self-administration. The prefilled autoinjectors are the major contributor to the global market., as more patients preferred disposable injectors due to ease of their usage and lower chances of any contamination.

Download Presentation

Global Autoinjector Market to Witness 16.9% CAGR During 2018 – 2024, Attaining the Market Size of USD 4.5 Billion by 202

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global AutoinjectorMarket enquiry@vynzresearch.com www.vynzresearch.com

  2. Industry Overview The global autoinjectors market is anticipated to grow at a CAGR of 16.9% during the forecast period with its market size reaching USD 4.5 billion by 2024. The market is growing at a significant rate due to mounting occurrence chronic and lifestyle associated diseases, escalating occurrence of anaphylaxis, and advancement in technology. Autoinjectors is a small device designed to deliver a specific dose of a particular drug. These are usually spring-loaded syringes that are mainly invented for comfortable and safe dispensation of the drugs. Different autoinjector products including prefilled and fillable injectors contributed to the autoinjectors market size. The market has witnessed high demand for disposable autoinjectors in the coming years due to advantages of disposable autoinjectors such as handiness, less probability of infection, and easiness of use. Explore Full Report Description at: https://www.vynzresearch.com/healthcare/autoinjectors-market

  3. market segmentation • Based on product, the autoinjector market is categorized into prefilled and fillable injectors. Of the two products, prefilled injectors hold the larger share in the market and it is predicted that the product category will also grow at the faster rate during the forecast period.

  4. Geographic Overview • Geographically, North America is the largest autoinjectors market as in the region the occurrence of chronic and autoimmune disease is increasing. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. • In addition, mounting occurrence of anaphylaxis, mounting healthcare expenditure and promising reimbursement situation are also up surging growth of the North American autoinjectors market. For instance, according to the National Health Interview Survey (NHIS), in 2014, 5.4 percent US children under age 18 suffered from food allergy. In addition, according to Food Allergy Research & Education, approximately 15 million Americans have food allergies.

  5. Competition among keyplayers • Key players in the autoinjectors market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In December 2016, Mylan N.V. launched the authorized generic for EpiPen, as an autoinjector. Abbvie, Ypsomed, Consort Medical, Johnson & Johnson, Mylan, Becton, Dickinson and Company, Amgen, Haselmeier, ELI Lilly, Owen Mumford, Scandinavian Health Limited and Antares Pharma are the key players offering autoinjectors.

  6. In THANK YOU! https://www.vynzresearch.com/healthcare/autoinjectors-market/request-sample enquiry@vynzresearch.com www.vynzresearch.com US/Canada Toll-Free: 1-888-253-3960

More Related